EUVIMEDEUVIMED entdecken
Crossref

Recombinant hemoglobin expression in mesenchymal stem cells followed by enucleation generates an oxygen carrier candidate

Xinyi Chen, Zhengrong Zhou, Shuxin Chen, Zihui Zhou, Yu Guo, Jialin Ding, Chiju Wei, Zhong Hu, Aihua Mao

Biochemical Engineering Journal · 2027-01 · 237 · 110409

DOI: 10.1016/j.bej.2026.110409 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Engineering Journal, 2027-01. Verfasst von Xinyi Chen und 8 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Gefördert von: Guangdong Basic and Applied Basic Research Foundation, Basic and Applied Basic Research Foundation of Guangdong Province, National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Shortages in donor blood supply necessitate the development of alternative oxygen carriers. This study reports the engineering of a novel biomimetic oxygen carrier derived from enucleated bone marrow mesenchymal stem cells (BMSCs). A bicistronic cassette encoding hemoglobin (Hb) α and β subunits linked by a P2A peptide was integrated into the BMSC genome via lentiviral transduction. This design enabled the tandem expression of both subunits, facilitating their self-assembly into functional tetramers, as confirmed by Western blot and native-PAGE analysis. The oxygen-binding functionality of the recombinant hemoglobin was characterized using UV-Vis spectroscopy, which demonstrated the characteristic spectral shifts for oxygenated (dual peaks) and deoxygenated (single peak) states, indicating oxygen-carrying capacity comparable to native hemoglobin. After induction of enucleation, the resulting cell-derived vesicles exhibited a size distribution similar to human erythrocytes and maintained functional viability for up to 24 h in vitro. Furthermore, these vesicles showed low cytotoxicity. In conclusion, the engineered enucleated BMSC-derived hemoglobin (BMSC-Hb) vesicles possess a promising combination of oxygen transport functionality and low immunogenicity risk, positioning them as a potential cell-free therapeutic platform for emergency transfusion applications.

Förderung

  • Guangdong Basic and Applied Basic Research Foundation
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • National Natural Science Foundation of China

Zitieren

APA

Chen, X., Zhou, Z., Chen, S., Zhou, Z., Guo, Y., Ding, J., Wei, C., Hu, Z., & Mao, A. (2027). Recombinant hemoglobin expression in mesenchymal stem cells followed by enucleation generates an oxygen carrier candidate. Biochemical Engineering Journal, 237, 110409. https://doi.org/10.1016/j.bej.2026.110409

Vancouver

Chen X, Zhou Z, Chen S, Zhou Z, Guo Y, Ding J, et al. Recombinant hemoglobin expression in mesenchymal stem cells followed by enucleation generates an oxygen carrier candidate. Biochemical Engineering Journal. 2027;237:110409. doi:10.1016/j.bej.2026.110409

BibTeX
@article{Chen2027,
  author = {Chen, Xinyi and Zhou, Zhengrong and Chen, Shuxin and Zhou, Zihui and Guo, Yu and Ding, Jialin and Wei, Chiju and Hu, Zhong and Mao, Aihua},
  title = {Recombinant hemoglobin expression in mesenchymal stem cells followed by enucleation generates an oxygen carrier candidate},
  journal = {Biochemical Engineering Journal},
  year = {2027},
  volume = {237},
  pages = {110409},
  doi = {10.1016/j.bej.2026.110409}
}
Kostenlos starten →